Managing Dengvaxia Miscommunication Through Risk
Total Page:16
File Type:pdf, Size:1020Kb
Managing Dengvaxia Miscommunication Through Risk Management Plan by Via Zareena Bulda and Naomi Maraviles National Change Organization LETTER OF TRANSMITTAL Via Zareena Bulda Block 18 Lot 54 Willow Street, Antel Grand Village, Bacao 2, General Trias, Cavite 4107 Dr. Francisco Duque III Department of Health Secretary San Lazaro Compound, Tayuman, Sta. Cruz, Manila, Philippines 1003 March 3, 2018 Dear Dr. Francisco Duque III, Attached to this letter is a report for the risk management development plan for the Dengvaxia controversy. The report is based on the findings and an overall report produced by the National Change Organization. The communication plan solely focused on giving alternative solutions to the victims of the Dengvaxia, by producing paper materials to be disseminated nationwide like brochures, leaflets, and posters containing general information, frequently asked questions, and contact details. The organization also aims to propose a partnership with the government to conduct seminars and require a task force in all hospitals, both public and private, to help and attend to the needs of the victims. After a thorough observation and investigation, the National Change Organization assures that the communication plan can help and guide the victims. If you have any questions or want to discuss this matter further, we can be reached at the above addresses, at (0955) 915 0366 and (0905) 511 3919, or at [email protected] and [email protected]. Sincerely, Via Zareena Bulda 2 Abstract This report focuses on informing the readers about the general information about Sanofi Pasteur, one of the largest companies in the world that specialize in vaccines; Dengvaxia, the anti-dengue vaccine that was created to save millions of lives; and alternative solutions that the National Change Organization came up with to address the issues related to Dengvaxia in the Philippines. Sanofi Pasteur was able to complete the necessary stages before being able to distribute the vaccines to 11 countries which are the Philippines, Mexico, Brazil, El Salvador, Costa Rica, Paraguay, Guatemala, Peru, Indonesia, Thailand, and Singapore. Months after the distribution, a paper by the World Health Organization was released and they ordered that governments should further look into the possible effects of Dengvaxia because it may be ineffective and unsafe to individuals who have never had dengue. Months after the Department of Health’s school-based immunization program, up to 40 cases of children’s deaths have been linked to Dengvaxia. The Senate has filed cases against the government officials who were involved in the implementation of the program, and they are under investigation. This caused confusion amongst the public and mistrust towards the government. The National Change Organization offers alternative solutions to resolve the controversy, which include dissemination of paper materials nationwide such as brochures, posters, and leaflets, social media platforms for announcements, possible partnership with the government to be able to conduct seminars and forums, and partnership with public and private hospitals nationwide to have a task force that will address the concerns of the vaccinated individuals. 3 List of Figures Figure 1: Distribution of Global Dengue Risk ...........................................................................13 Figure 2: Overview of Sanofi Pasteur ........................................................................................14 4 Table of Contents Letter of Transmittal .....................................................................................................................2 Abstract ...........................................................................................................................................3 List of Tables ..................................................................................................................................4 Executive Summary .......................................................................................................................6 National Change Organization .....................................................................................................6 Business Mission ......................................................................................................................6 Business Goals and Objectives .................................................................................................6 Introduction to the Report ............................................................................................................7 About Dengvaxia ..........................................................................................................................7 Statement of the Problem .............................................................................................................9 Significance ................................................................................................................................10 Scope and Limitations ................................................................................................................10 Purpose .......................................................................................................................................10 Objectives ...................................................................................................................................11 Introduction to Dengvaxia ..........................................................................................................12 Dengue Fever .............................................................................................................................12 Dengvaxia Vaccine ....................................................................................................................12 Timeline .....................................................................................................................................14 Related Events ............................................................................................................................17 Effects of Dengvaxia Vaccine ......................................................................................................19 Incidents .....................................................................................................................................19 Effects and Impacts ....................................................................................................................20 National Change Organization’s Risk Management Plan .......................................................21 Risk Management Plan Goals and Objectives ..........................................................................21 Mitigation of Problem ...............................................................................................................22 Strategies ................................................................................................................................22 Attainability ............................................................................................................................23 Benefits of the Dengvaxia Risk Management Plan ...................................................................23 Conclusion ....................................................................................................................................24 Conclusion ..................................................................................................................................24 Recommendations ......................................................................................................................25 Appendices ....................................................................................................................................27 List of Sources ..............................................................................................................................28 5 EXECUTIVE SUMMARY NATIONAL CHANGE ORGANIZATION National Change Organization, widely known as the NCO, is one of the top non-profit organizations in the Philippines. Established last January 1, 2018, the organization continues to grow up to this day with the expectation of rapid expansion in the risk communication industry. Formed by Via Zareena Bulda and Naomi Joy Maraviles, BS Technical Communication graduates of Mapua University, in hopes of making relevant changes in the country. NCO aims to serve, help, and reach out to the needs of the people of the Republic of the Philippines by providing alternative solutions to resolve countless issues and controversies. Business Mission One of the organization’s biggest achievements is that they were already able to provide alternative solutions, in partnership with the city of Manila, to reduce poverty in the urban areas. New Services The organization is beyond prepared to introduce their alternative solutions to resolve the Dengvaxia controversy: Paper Materials: NCO will be designing and disseminating leaflets, brochures, and posters nationwide that contains general information, frequently asked questions about Dengvaxia, and contact details that vary depending on location. Seminars and Forums: NCO will collaborate with the government to conduct seminars, entitled “Magandang Kalusugan Para sa Magandang Kinabukasan,” and forums that will open opportunities for a thorough face-to-face interaction. Dengvaxia Task Force/Groups: